Thomas Kuhnt
Overview
Explore the profile of Thomas Kuhnt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
897
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruhle A, Weymann M, Behrens M, Olbrich J, Kut C, Marschner S, et al.
Radiother Oncol
. 2024 Dec;
204:110697.
PMID: 39725066
Purpose: Cumulative cisplatin doses of ≥ 200 mg/m improve survival in adults with head-and-neck squamous cell carcinoma (HNSCC) undergoing chemoradiation, but many older adults with HNSCC cannot receive this prognostically...
2.
Wichmann G, Wald T, Pirlich M, Napp J, Munter I, Asendorf T, et al.
Front Oncol
. 2024 Sep;
14:1433238.
PMID: 39239277
Clinical Trial Registration: clinicaltrials.gov, identifier NCT06137378.
3.
Ruhle A, Kuhnt T
Strahlenther Onkol
. 2024 Jul;
200(11):1000-1004.
PMID: 39073461
No abstract available.
4.
Wichmann G, Wald T, Pirlich M, Stoehr M, Zebralla V, Kuhnt T, et al.
Front Oncol
. 2024 Jun;
14:1394691.
PMID: 38919522
Introduction: Larynx organ preservation (LOP) in locoregional-advanced laryngeal and hypopharyngeal squamous cell carcinoma (LA-LHSCC) being only R0-resectable (clear margins > 5 mm) by total laryngectomy (TL) is desirable. Based on...
5.
Prasse G, Glaas A, Meyer H, Zebralla V, Dietz A, Hering K, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001684
Background: In treatment of oropharyngeal squamous cell carcinoma (OPSCC), human papillomavirus status (HPV) plays a crucial role. The HPV-positive subtype tends to affect younger patients and is associated with a...
6.
Ruhle A, Weymann M, Behrens M, Marschner S, Haderlein M, Fabian A, et al.
Int J Radiat Oncol Biol Phys
. 2023 Nov;
118(5):1282-1293.
PMID: 37914144
Purpose: The number of older adults with head and neck squamous cell carcinoma (HNSCC) is increasing, and treatment of these patients is challenging. Although cisplatin-based chemotherapy concomitantly with radiation therapy...
7.
Jeong S, Poudyal S, Klagges S, Kuhnt T, Papsdorf K, Hambsch P, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835539
Background: Brain metastases (BM) cause relevant morbidity and mortality in cancer patients. The presence of cerebrovascular diseases can alter the tumor microenvironment, cellular proliferation and treatment resistance. However, it is...
8.
Osterhoff G, Kreinest M, Kuhnt T, Pohlenz C, Muller-Broich J, Rollig C, et al.
Global Spine J
. 2023 Apr;
13(1_suppl):85S-93S.
PMID: 37084345
Study Design: Mutlidisciplinary consensus recommendations for patients suffering from multiple myeloma (MM) involvement of the spinal column by the Spine Section of the German Association of Orthopaedic and Trauma Surgeons....
9.
Wiegand S, Wichmann G, Vogt J, Vogel K, Franke A, Kuhnt T, et al.
Front Oncol
. 2023 Apr;
13:1128176.
PMID: 37025596
Most of the patients with head and neck squamous cell carcinoma (HNSCC) are diagnosed with locally advanced disease. Standards of care for curative-intent treatment of this patient group are either...
10.
Schweyen R, Reich W, Jevnikar P, Kuhnt T, Wienke A, Hey J
J Clin Med
. 2022 Nov;
11(21).
PMID: 36362546
During prosthetic rehabilitation after tumor therapy (TT) in the head and neck region, the dentist must assess whether the prognosis of the remaining teeth is sufficiently good or whether implants...